Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Patrick Kesteven.

Newcastle AuthorsTitleYearFull text
Dr Kathryn Musgrave
Jonathan Scott
Dr Wezi Sendama
Dr Patrick Kesteven
Dr Marie-Helene Ruchaud
et al.
The differential surface expression of tissue factor between monocyte subsets2020
Salah Abohelaika
Dr Hilary Wynne
Dr Peter Avery
Dr Patrick Kesteven
Professor Farhad Kamali
et al.
Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management2016
Dr Kate Musgrave
Professor John Simpson
Dr Patrick Kesteven
Is there any clinical or biological difference that distinguishes recurrence from non-recurrence after idiopathic PE?2016
Dr Patrick Kesteven
The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry2015
Salah Abohelaika
Professor Farhad Kamali
Dr Peter Avery
Dr Patrick Kesteven
Dr Hilary Wynne
et al.
Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England2014
Basav Sen
Dr Patrick Kesteven
Dr Peter Avery
Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED)2014
Dr Patrick Kesteven
Professor Ann Daly
Dr Peter Avery
Professor Farhad Kamali
A Randomized Trial Comparing Genotype-Guided Dosing of Warfarin to Standard Dosing: The EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Warfarin Study2013
Dr Patrick Kesteven
Julian Leathart
Professor Ann Daly
Professor Farhad Kamali
A Randomized Trial of Genotype-Guided Dosing of Warfarin2013
Professor Farhad Kamali
Dr Hilary Wynne
Dr Patrick Kesteven
Dr John Hanley
Dr Jing Shen
et al.
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K2013
Dr Logan Thirugnanasothy
Dr Patrick Kesteven
Professor John Dark
Pulmonary embolism: Surgical embolectomy is underused2013
Dr Arun Natarajan
Emerita Professor Sally Marshall
Dr Patrick Kesteven
Dr Janet McComb
Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes2011
Mohamed Noormohamed
Susan Stamp
Dr Brian Shenton
Dr Patrick Kesteven
Dr Noel Carter
et al.
Effects of extra corporeal membrane oxygenation (ECMO) on liver function and histology, in a porcine model of uncontrolled non heart beating donor (NHBD)2010
Dr Montserrat Briz Del Blanco
Dr Katherine Talks
Dr John Hanley
Dr Patrick Kesteven
Professor Ann Daly
et al.
Reversal of warfarin-induced over-anticoagulation with individualized dosing of oral vitamin K: a pilot study2010
Dr Katherine Talks
Dr John Hanley
Dr Patrick Kesteven
Dr Peter Avery
Professor Ann Daly
et al.
Individualised oral vitamin K for reversal of warfarin excessive anticoagulation2009
Dr Jonathan Smout
Dr Alexander Dyker
Professor Gary Ford
Dr Patrick Kesteven
Professor Gerard Stansby
et al.
Platelet Function Following Acute Cerebral Ischemia2009
Dr Patrick Kesteven
Dr Katherine Talks
Dr John Hanley
A retrospective audit of a standard protocol for the rapid reversal of warfarin in patients with intracranial haemorrhage2007
Dr Patrick Kesteven
Early discharge of patients with pulmonary embolism: a two-phase observational study2007
Dr Brian Angus
Dr Patrick Kesteven
Localized reactive angioendotheliomatosis2007
Sheryl Mitchell
Elizabeth Lingard
Dr Patrick Kesteven
Professor Andrew McCaskie
Craig Gerrand
et al.
Venous Thromboembolism in Patients with Primary Bone or Soft-Tissue Sarcomas2007
Wei Zhang
Dr Patrick Kesteven
Which patients with venous thrombosis do not require screening for malignancy? A predictive model to identify patients with VTE at minimal risk of malignancy2007
James McCaslin
Dr Jonathan Smout
Dr Patrick Kesteven
Professor Gerard Stansby
Oral antiplatelet agents and bleeding risk in relation to major cardiovascular surgery2006
Dr Patrick Kesteven
Outpatient management of pulmonary embolism: results from the national Multicentre PE study2006
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Patrick Kesteven
Dr Peter Avery
et al.
[abstract] Pfizer poster communication prize - The influence of patient age, CYP2C9 genotype and height on warfarin dose requirements2005
Elizabeth Sconce
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Peter Avery
Dr Barry King
et al.
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen2005
John Hamilton
Dr Jon Smith
Dr Jonathan Wallis
Dr Patrick Kesteven
Dr John O'Sullivan
et al.
ABO-incompatible heart transplantation in infants: The Freeman Hospital experience2004
Professor Farhad Kamali
Dr Tayyaba Khan
Dr Barry King
Dr Patrick Kesteven
Peter Wood
et al.
Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin2004
Dr Tayyaba Khan
Dr Hilary Wynne
Dr Peter Avery
Dr Patrick Kesteven
Professor Farhad Kamali
et al.
Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin2004
Dr Jonathan Smout
Dr Alexander Dyker
Dr Patrick Kesteven
Professor Gerard Stansby
Do soluble and platelet surface P-selectin levels correlate with conventional markers of platelet activation?2004
Dr Tayyaba Khan
Professor Farhad Kamali
Dr Patrick Kesteven
Dr Peter Avery
Dr Hilary Wynne
et al.
The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation2004
Dr Patrick Kesteven
A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation2003
Dr Patrick Kesteven
Ritu Arya
Long haul flights and deep vein thrombosis: Who is at risk?2003
Dr Hilary Wynne
Dr Patrick Kesteven
Professor Farhad Kamali
The impact of stability of oral anticoagulant therapy upon patient perceived health status and quality of life2003
Dr Patrick Kesteven
Incidence of symptomatic thrombosis in a stable population of 650,000: Travel and other risk factors2002
Dr Janet McComb
Dr Patrick Kesteven
Emerita Professor Sally Marshall
QT prolongation in patients with Type 2 diabetes and microalbuminuria2002
Dr Patrick Kesteven
The role of strain gauge plethysmography in the assessment of patients with suspected deep vein thrombosis2002
Dr Patrick Kesteven
Clinical risk factors for venous thrombosis associated with air travel2001
Dr Ahmed Chishti
Professor John Dark
Dr Patrick Kesteven
Dr Hazel Powell
Dr Christopher Snowden
et al.
Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass2001
Dr Patrick Kesteven
Dr Peter Saunders
Model for assessment of endothelial cell function and viability using the MTT dye test and [3H]2001
Dr Patrick Kesteven
Superficial thrombophlebitis followed by pulmonary embolism2001
Professor Farhad Kamali
Dr Hilary Wynne
Dr Patrick Kesteven
Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans2001
Dr Akif Gani
Dr Patrick Kesteven
Dr Richard Lendrum
Aortic stenosis and bleeding from angiodysplasia in elderly patients: Is acquired Von Willebrand's disease the link1999
Professor Chris Day
Dr Patrick Kesteven
Professor Ann Daly
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications1999
Dr Janet McComb
Dr Patrick Kesteven
Emerita Professor Sally Marshall
Professor Graham Jackson
Endothelial dysfunction, disordered coagulation and fibrinolysis in patients with type 2 diabetes and microalbuminuria1999
Dr Patrick Kesteven
Dr Janet McComb
Emerita Professor Sally Marshall
Reduced ankle brachial index is strongly linked to albumin excretion rate and white cell count but not to measures of endothelial dysfunction or coagulation in NIDDM1999
Professor Chris Day
Dr Patrick Kesteven
Professor Ann Daly
Warfarin dose requirement and CYP2C9 polymorphisms - Reply1999